COMPLEMENT ACTIVATION AS A CAUSE FOR PRIMARY GRAFT FAILURE IN AN ISOGENEIC RAT MODEL OF HYPOTHERMIC LUNG PRESERVATION AND TRANSPLANTATION
- 1 November 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 64 (9) , 1248-1255
- https://doi.org/10.1097/00007890-199711150-00004
Abstract
Although agents that inhibit complement activation may be beneficial in discordant xenotransplantation, it is not known whether local complement activation occurs and is deleterious after isogeneic lung transplantation. Lungs were harvested from Lewis rats subjected to 4 °C 6-hr preservation followed by transplantation into strain-, gender-, and weight-matched recipients. Transplanted lungs demonstrated increased immunostaining for C5b-9 compared with nontransplanted controls, confirming local complement activation in this isograft model. To investigate the physiologic relevance of complement activation in the transplanted lung, the native pulmonary artery was ligated after transplantation, and pulmonary vascular resistance (mmHg/ml/min), arterial oxygenation (mmHg), graft neutrophil infiltration (myeloperoxidase activity, ΔAbs 460 nm/min), and recipient survival were measured at 30 min. Animals received either saline (control; n=22) or soluble complement receptor type-1 (sCR1, 15 mg/kg; n=19) 2 min before reperfusion. Animals treated with sCR1 showed a marked reduction in serum complement hemolytic activity (CH50; 90% lower than that of control animals,PPPPP.Keywords
This publication has 31 references indexed in Scilit:
- PROLONGATION OF CARDIAC XENOGRAFT SURVIVAL BY DEPLETION OF COMPLEMENTTransplantation, 1993
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990
- The complement system in ischemic heart disease.Circulation, 1990
- Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effectsBiochemical Journal, 1989
- Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury.Circulation, 1988
- Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.The Journal of Experimental Medicine, 1982
- Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.Journal of Clinical Investigation, 1982
- Complement Localization and Mediation of Ischemic Injury in Baboon MyocardiumJournal of Clinical Investigation, 1980
- Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membraneProceedings of the National Academy of Sciences, 1979
- Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery OcclusionJournal of Clinical Investigation, 1978